CD20I - Overview: CD20 Immunostain, Technical Component Only
Classification of lymphomas
GRH - Overview: Growth Hormone Immunostain, Technical Component Only
Aids in the identification of growth hormone adenomas
MAGU - Overview: Magnesium, 24 Hour, Urine
Assessing the cause of abnormal serum magnesium concentrations using a 24-hour urine collection Determining whether nutritional magnesium loads are adequate Calculating urinary calcium oxalate and calcium phosphate supersaturation and...
MNU - Overview: Manganese, 24 Hour, Urine
Monitoring manganese exposure using 24 hour urine collections Nutritional monitoring
MYOGL - Overview: Myoglobin Immunostain, Technical Component Only
Marker of skeletal and cardiac muscle
C5B9 - Overview: SC5b-9 Level Terminal Complement Complex, Plasma
Detecting increased complement activation
ALCU - Overview: Aluminum/Creatinine Ratio, Urine
Measurement of aluminum concentration as a part of assessing for aluminum exposure
HE4 - Overview: Human Epididymis Protein 4, Serum
Aiding in monitoring patients with treated epithelial ovarian cancer for recurrence or progression This test should not be used as a screening test for ovarian cancer.
HER2I - Overview: HER2 Immunostain, Technical Component Only
Qualitative detection of HER2 protein overexpression in a diagnostic setting in formalin-fixed paraffin-embedded tissue sections
LDPU - Overview: Limited Drug Profile, 3 Drug Classes, Immunoassay, Random, Urine
Detecting drug use involving barbiturates, cocaine, and carboxy-tetrahydrocannabinol This test is not intended for use in employment-related testing.
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....